Publications by authors named "O Pav"

Claim this Profile
D
Discovery of isonucleotidic CDNs as potent STING agonists with immunomodulatory potential.
Milan Dejmek, Michal Šála, Andrea Brazdova, Lenka Vanekova, Miroslav Smola

Structure· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Corrigendum to "5'-Phosphonate modified oligoadenylates as potent activators of human RNase L" [Bioorg. Med. Chem. 56 (2022) 116632].
Tomáš Lášek, Magdalena Petrová, Ivana Košiová, Ondřej Šimák, Miloš Buděšínský

Bioorg Med Chem· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
5
5'-Phosphonate modified oligoadenylates as potent activators of human RNase L.
Tomáš Lášek, Magdalena Petrová, Ivana Košiová, Ondřej Šimák, Miloš Buděšínský

Bioorg Med Chem· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Ad-MD method to calculate NMR shift including effects due to conformational dynamics: The P NMR shift in DNA.
Jiří Fukal, Miloš Buděšínský, Ondřej Páv, Petr Jurečka, Marie Zgarbová

J Comput Chem· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthesis and Biological Evaluation of Phosphoester and Phosphorothioate Prodrugs of STING Agonist 3',3'-c-Di(2'F,2'dAMP).
Markéta Pimková Polidarová, Petra Břehová, Martin Maxmilian Kaiser, Miroslav Smola, Martin Dračínský

J Med Chem· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis